semaglutide and tirzepatide. vs Tirzepatide: Which Is Better for Weight Loss? Semaglutide vs Tirzepatide for Weight

E.MurrayI

When a Patient Should Discuss Heart Risk Before GLP-1 Therapy Patients should discuss cardiovascular risk before starting GLP-1 therapy if they have a history of heart attack, stroke, coronary artery disease, stents, heart failure, high blood pressure, high cholesterol, diabetes, kidney disease, sleep apnea, fatty liver disease, or a strong family history of heart disease

Spatial omics further enhance this understanding by providing essential spatial context regarding the functions and interactions of drug targets

If Semaglutide proves effective in reducing inflammation and inducing remission in Crohns Disease, it could potentially reduce the reliance on corticosteroids, thereby minimizing the risks associated with their prolonged use